|
1
|
Dobrotina AF and Zlotnikova ZB:
Generalized sarcomatosis (lymphosarcomatosis) in pregnancy with
unusual bilateral involvement of the breasts. Vopr Onkol.
5:613–616. 1959.(In Russian). PubMed/NCBI
|
|
2
|
Aviv A, Tadmor T and Polliack A: Primary
diffuse large B-cell lymphoma of the breast: Looking at
pathogenesis, clinical issues and therapeutic options. Ann Oncol.
24:2236–2244. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Caon J, Wai ES, Hart J, Alexander C,
Truong PT, Sehn LH and Connors JM: Treatment and outcomes of
primary breast lymphoma. Clin Breast Cancer. 12:412–419. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jeanneret-Sozzi W, Taghian A, Epelbaum R,
Poortmans P, Zwahlen D, Amsler B, Villette S, Belkacémi Y, Nguyen
T, Scalliet P, et al: Primary breast lymphoma: Patient profile,
outcome and prognostic factors. A multicentre Rare Cancer Network
study. BMC Cancer. 8:862008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ryan G, Martinelli G, Kuper-Hommel M,
Tsang R, Pruneri G, Yuen K, Roos D, Lennard A, Devizzi L, Crabb S,
et al: Primary diffuse large B-cell lymphoma of the breast:
Prognostic factors and outcomes of a study by the International
Extranodal Lymphoma Study Group. Ann Oncol. 19:233–241. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Talwalkar SS, Miranda RN, Valbuena JR,
Routbort MJ, Martin AW and Medeiros LJ: Lymphomas involving the
breast: A study of 106 cases comparing localized and disseminated
neoplasms. Am J Surg Pathol. 32:1299–1309. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Surov A, Holzhausen HJ, Wienke A, Schmidt
J, Thomssen C, Arnold D, Ruschke K and Spielmann RP: Primary and
secondary breast lymphoma: Prevalence, clinical signs and
radiological features. Br J Radiol. 85:e195–e205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arber DA, Simpson JF, Weiss LM and
Rappaport H: Non-Hodgkin's lymphoma involving the breast. Am J Surg
Pathol. 18:288–295. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uesato M, Miyazawa Y, Gunji Y and Ochiai
T: Primary non-Hodgkin's lymphoma of the breast: Report of a case
with special reference to 380 cases in the Japanese literature.
Breast Cancer. 12:154–158. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Validire P, Capovilla M, Asselain B,
Kirova Y, Goudefroye R, Plancher C, Fourquet A, Zanni M, Gaulard P,
Vincent-Salomon A and Decaudin D: Primary breast non-Hodgkin's
lymphoma: A large single center study of initial characteristics,
natural history, and prognostic factors. Am J Hematol. 84:133–139.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yhim HY, Kang HJ, Choi YH, Kim SJ, Kim WS,
Chae YS, Kim JS, Choi CW, Oh SY, Eom HS, et al: Clinical outcomes
and prognostic factors in patients with breast diffuse large B cell
lymphoma: Consortium for Improving Survival of Lymphoma (CISL)
study. BMC Cancer. 10:3212010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao YB, Sun XF, He YN, Liu CJ and Liu H:
Clinicopathological features of thirty patients with primary breast
lymphoma and review of the literature. Med Oncol. 32:4482015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hosein PJ, Maragulia JC, Salzberg MP,
Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirani R,
Evens AM, et al: A multicentre study of primary breast diffuse
large B-cell lymphoma in the rituximab era. Br J Haematol.
165:358–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cheah CY, Campbell BA and Seymour JF:
Primary breast lymphoma. Cancer Treat Rev. 40:900–908. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wiseman C and Liao KT: Primary lymphoma of
the breast. Cancer. 29:1705–1712. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hugh JC, Jackson FI, Hanson J and Poppema
S: Primary breast lymphoma. An immunohistologic study of 20 new
cases. Cancer. 66:2602–2611. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the committee on Hodgkin's
disease staging classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
18
|
Harris NL, Jaffe ES, Diebold J, Flandrin
G, Muller-Hermelink HK, Vardiman J, Lister TA and Bloomfield CD:
The World Health Organization classification of hematological
malignancies report of the clinical Advisory Committee Meeting,
Airlie House, Virginia, November 1997. Mod Pathol. 13:193–207.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miller TP, Dahlberg S, Cassady JR,
Adelstein DJ, Spier CM, Grogan TM, LeBlanc M, Carlin S, Chase E and
Fisher RI: Chemotherapy alone compared with chemotherapy plus
radiotherapy for localized intermediate- and high-grade
non-Hodgkin's lymphoma. N Engl J Med. 339:21–26. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheson BD, Horning JS, Coiffier B, Shipp
MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A,
Hagenbeek A, et al: Report of an international workshop to
standardize response criteria for non-Hodgkin's lymphomas. NCI
Sponsored International Working Group. J Clin Oncol. 17:1244–1253.
1999.PubMed/NCBI
|
|
21
|
Hans CP, Weisenburger DD, Greiner TC,
Gascoyne RD, Delabie J, Ott G, Müller-Hermelink HK, Campo E,
Braziel RM, Jaffe ES, et al: Confirmation of the molecular
classification of diffuse large B-cell lymphoma by
immunohistochemistry using a tissue microarray. Blood. 103:275–282.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yhim HY, Kim JS, Kang HJ, Kim SJ, Kim WS,
Choi CW, Eom HS, Kim JA, Lee JH, Won JH, et al: Matched-pair
analysis comparing the outcomes of primary breast and nodal diffuse
large B cell lymphoma in patients treated with rituximab plus
chemotherapy. Int J Cancer. 131:235–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Avilés A, Castañeda C, Neri N, Cleto S and
Nambo MJ: Rituximab and dose dense chemotherapy in primary breast
lymphoma. Haematologica. 92:1147–1148. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Avilés A, Delgado S, Nambo MJ, Neri N,
Murillo E and Cleto S: Primary breast lymphoma: Results of a
controlled clinical trial. Oncology. 69:256–260. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jennings WC, Baker RS, Murray SS, Howard
CA, Parker DE, Peabody LF, Vice HM, Sheehan WW and Broughan TA:
Primary breast lymphoma: The role of mastectomy and the importance
of lymph node status. Ann Surg. 245:784–789. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Habermann TM, Weller EA, Morrison VA,
Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI,
Peterson BA and Horning SJ: Rituximab-CHOP versus CHOP alone or
with maintenance rituximab in older patients with diffuse large
B-cell lymphoma. J Clin Oncol. 24:3121–3127. 2006. View Article : Google Scholar : PubMed/NCBI
|
